Network-Based Support to Help Community Coalition Members Choose and Use Strategies to Improve Child Health
2026年8月31日 更新者：Travis R Moore、University of Pittsburgh
Pilot Trial of Network-Based Implementation Strategies to Increase Coalition Adoption and Early Implementation of Evidence-Informed Strategies for Child Health
Community coalitions bring together residents and organizations to improve child health, but they may need support to identify and put research-supported strategies into practice. This study will examine whether a program called FICAS can be delivered successfully and is useful to coalition members. FICAS uses information about relationships within a coalition to help involve people with relevant perspectives, share evidence, compare possible strategies, make decisions, and adjust support as the coalition's work develops.
Three community coalitions will participate. All three will eventually receive Catalyzing Communities, a program that provides facilitated meetings, collaborative planning, technical assistance, and funding for coalition-led action. One coalition will begin the program later, one will receive Catalyzing Communities alone, and one will receive Catalyzing Communities with FICAS. The study will help determine whether FICAS and the study procedures should be refined and tested in a larger study.
調査の概要
状態
状態
まだ募集していません
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
介入
入学 (推定)
入学
3300
段階
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
研究連絡先
- 名前：Travis R Moore, PhD
- 電話番号：512-914-4880
- メール：trm250@pitt.edu
研究連絡先のバックアップ
- 名前：Yuilyn A Chang Chusan, MS
- メール：Yuilyn.Chang_Chusan@tufts.edu
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15216
- University of Pittsburgh
-
コンタクト：
- Travis R Moore, PhD
- 電話番号：512-914-4880
- メール：trm250@pitt.edu
-
主任研究者：
- Travis R Moore, PhD
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
はい
説明
Inclusion Criteria
Coalition-level criteria
- Coalition focuses on child health, childhood obesity prevention, healthy eating, active living, nutrition security, policy, systems, or environmental change, or related community health priorities.
- Coalition works in or serves a community experiencing socioeconomic disadvantage.
- Coalition has multisector participation.
- Coalition has identifiable leadership or backbone capacity to participate in the study.
- Coalition is willing to participate in study procedures and data collection and accept randomized coalition-level assignment.
- Coalition has a feasible membership roster or is able to work with the study team to construct one and has an identifiable leadership contact.
- Coalition can support participant recruitment and scheduling without coercing individual participation.
Individual-level criteria
- Age 18 years or older.
- Coalition member, leader, staff member, partner, changemaker, committee or core-group participant, named network connection, survey-only participant, invited guest, or other adult with relevant community, organizational, policy, professional, or implementation expertise or connections.
- Able to provide informed consent.
- Able to participate in English.
- For direct committee or core-group participants, able to participate through the internet, telephone, or another study-supported mode.
- Willing to complete the study activities applicable to the participant's role, which may include meetings, surveys, network assessments, or interviews.
Exclusion Criteria
Coalition-level criteria
- Coalition is unable to participate in required study activities.
- Coalition lacks a feasible membership roster or the ability to construct one with study-team assistance, or lacks an identifiable leadership contact.
- Coalition is unwilling to accept randomized coalition-level assignment.
- Coalition is participating in a comparable formal coalition intervention that would prevent interpretation of the study findings.
Individual-level criteria
- Younger than 18 years.
- Unable to provide informed consent.
- Unable to participate in English.
- Does not have an eligible coalition, professional, community, organizational, policy, or implementation role, expertise, or connection.
- For direct committee or core-group participants, unable to participate through an available study-supported mode.
- Participation would create an unmanaged conflict or undue pressure that cannot be resolved.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：ランダム化
- 介入モデル：順次割り当て
- マスキング：なし（オープンラベル）
アーム数
3
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
他の：Delayed Control
During the initial comparison period, this coalition will receive study assessments and retention contacts but no active Catalyzing Communities or FICAS intervention.
After the prespecified pre-crossover assessment, the coalition will cross over to Catalyzing Communities only.
It will not receive the FICAS augmentation during the registered comparison period.
|
Catalyzing Communities is a coalition-centered implementation-support platform that includes facilitated coalition convening, group model building, technical assistance, and seed funding.
The platform supports shared systems understanding, identification of action opportunities, selection of an evidence-informed strategy, action planning, and early coalition-led implementation.
Activities may be delivered virtually or in person and continue across the active intervention period.
|
|
アクティブコンパレータ：Positive Control: Catalyzing Communities
This coalition will receive the Catalyzing Communities base implementation-support platform, including coalition convening, group model building, technical assistance, and seed funding to support coalition-led selection and early implementation of an evidence-informed strategy.
It will not receive the FICAS augmentation.
|
Catalyzing Communities is a coalition-centered implementation-support platform that includes facilitated coalition convening, group model building, technical assistance, and seed funding.
The platform supports shared systems understanding, identification of action opportunities, selection of an evidence-informed strategy, action planning, and early coalition-led implementation.
Activities may be delivered virtually or in person and continue across the active intervention period.
|
|
実験的：Augmented Treatment: Catalyzing Communities Plus FICAS
This coalition will receive the Catalyzing Communities base implementation-support platform plus the FICAS multicomponent implementation intervention.
FICAS adds data-informed committee selection, opinion leader engagement, structured evidence review, structured decision support, and online network monitoring and adaptation.
|
Catalyzing Communities is a coalition-centered implementation-support platform that includes facilitated coalition convening, group model building, technical assistance, and seed funding.
The platform supports shared systems understanding, identification of action opportunities, selection of an evidence-informed strategy, action planning, and early coalition-led implementation.
Activities may be delivered virtually or in person and continue across the active intervention period.
FICAS is a multicomponent implementation intervention delivered as an augmentation to Catalyzing Communities.
It includes five strategies: using roster and network data to strengthen committee representation and connectivity; identifying and engaging influential or bridging coalition members; progressively assembling and reviewing research, practice, community, and policy evidence; using structured criteria and deliberation to select an evidence-informed strategy; and monitoring coalition network data to guide adaptations.
Components are delivered at relevant milestones across evidence review, strategy selection, and early implementation.
|
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Participation and Reach
時間枠：From the beginning of participant recruitment through the primary assessment window, up to 12 months after intervention initiation
|
The number of eligible coalition members who provide informed consent and complete at least one study data-collection activity will be divided by the total number of eligible coalition members invited to participate and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater study reach.
|
From the beginning of participant recruitment through the primary assessment window, up to 12 months after intervention initiation
|
|
Percentage of Enrolled Participants Retained Through the Primary Endpoint
時間枠：Baseline through intervention month 12
|
The number of participants in the baseline cohort who complete the final scheduled primary assessment will be divided by the number enrolled in the baseline cohort and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater retention.
|
Baseline through intervention month 12
|
|
Mean Acceptability of Intervention Measure Score for FICAS
時間枠：Intervention months 6, 9, and 12
|
Acceptability of FICAS will be measured using the four-item Acceptability of Intervention Measure.
Each item is scored from 1, completely disagree, to 5, completely agree.
Item scores will be averaged to produce a mean score ranging from 1 to 5. Higher scores indicate greater perceived acceptability.
Mean scores will be reported separately at each assessment.
|
Intervention months 6, 9, and 12
|
|
Mean Intervention Appropriateness Measure Score for FICAS
時間枠：Intervention months 6, 9, and 12
|
Perceived appropriateness of FICAS will be measured using the four-item Intervention Appropriateness Measure.
Each item is scored from 1, completely disagree, to 5, completely agree.
Item scores will be averaged to produce a mean score ranging from 1 to 5. Higher scores indicate greater perceived appropriateness.
Mean scores will be reported separately at each assessment.
|
Intervention months 6, 9, and 12
|
|
Mean Feasibility of Intervention Measure Score for FICAS
時間枠：Intervention months 6, 9, and 12
|
Perceived feasibility of FICAS will be measured using the four-item Feasibility of Intervention Measure.
Each item is scored from 1, completely disagree, to 5, completely agree.
Item scores will be averaged to produce a mean score ranging from 1 to 5. Higher scores indicate greater perceived feasibility.
Mean scores will be reported separately at each assessment.
|
Intervention months 6, 9, and 12
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Percentage of Selected-Strategy Adoption Milestones Completed
時間枠：Intervention months 9 and 12
|
Coalition progress will be assessed using eight prespecified milestones: naming and actively considering a candidate strategy, formally selecting a strategy, assigning implementation roles, drafting an implementation plan, securing resources or commitments, completing launch preparation, initiating the first implementation activity, and beginning early monitoring or refinement.
Each completed milestone receives one point.
The number completed will be divided by eight and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater progress from strategy consideration through adoption and early action.
|
Intervention months 9 and 12
|
|
Normalized Early Implementation Readiness and Action-Initiation Score
時間枠：Intervention months 9 and 12
|
Readiness and action initiation will be assessed using a nine-indicator study-specific rubric.
Indicators address confirmation of the selected strategy, implementation leadership, assigned responsibilities, a written implementation plan, timelines and milestones, resources and supports, partner commitments, launch preparation, and initiation of the first implementation action.
Each applicable indicator is scored from 0, no evidence, to 3, completed or fully documented.
Scores will be summed, divided by the maximum possible score for applicable indicators, and multiplied by 100.
Scores range from 0 to 100.
Higher scores indicate greater implementation readiness and action initiation.
|
Intervention months 9 and 12
|
|
Coalition Child-Health Discussion Network Density
時間枠：Pre-intervention baseline and monthly through intervention month 12
|
At each assessment, participants may identify up to 20 people with whom they currently discuss child health promotion.
Coalition network density will be calculated as the number of observed directed child-health discussion ties among rostered coalition members divided by the total number of possible directed ties, excluding self-ties.
Scores range from 0 to 1. Higher values indicate a more densely connected coalition discussion network.
|
Pre-intervention baseline and monthly through intervention month 12
|
|
Percentage of Child-Health Discussion Ties Connecting Different Sectors
時間枠：Pre-intervention baseline and monthly through intervention month 12
|
The number of reported child-health discussion ties connecting people from different organizational or community sectors will be divided by the number of reported ties with sector information and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater cross-sector connectivity.
|
Pre-intervention baseline and monthly through intervention month 12
|
|
Percentage of Prespecified Strategic Representation Categories Represented
時間枠：Pre-intervention baseline and intervention months 6, 9, and 12
|
Before intervention delivery, the study team and coalition will identify the sectors, roles, perspectives, and community constituencies needed for the coalition or core committee.
At each assessment, the number of prespecified categories represented by at least one active member will be divided by the total number of prespecified categories and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater strategic representation.
|
Pre-intervention baseline and intervention months 6, 9, and 12
|
|
Mean Coalition-Wave Dyadic Trust Score
時間枠：Pre-intervention baseline and monthly through intervention month 12
|
Participants will rate each named coalition connection using one item, "How much do you trust this person?"
Responses range from 1, I do not trust this person, to 5, I trust this person.
A mean trust score will first be calculated across each respondent's rated ties.
Respondent-level means will then be averaged within each coalition and assessment wave.
Scores range from 1 to 5. Higher scores indicate greater trust among coalition members.
|
Pre-intervention baseline and monthly through intervention month 12
|
|
Mean Number of Child-Health Discussion Ties per Participant
時間枠：Pre-intervention baseline and monthly through intervention month 12
|
At each assessment, participants may identify up to 20 people with whom they currently discuss child health promotion.
The number of reported discussion ties will be calculated for each participant and averaged within each coalition.
Scores range from 0 to 20 ties per participant.
Higher values indicate that participants report more child-health discussion connections.
|
Pre-intervention baseline and monthly through intervention month 12
|
|
Mean Perceived Relative Advantage Score for the Selected Evidence-Informed Strategy
時間枠：Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
relative advantage will be assessed using five adapted items from the Moore and Benbasat Perceived Characteristics of Innovating instrument.
Each item is scored from 1, extremely disagree, to 7, extremely agree.
Item scores will be averaged.
Scores range from 1 to 7. Higher scores indicate greater perceived advantage of the selected strategy compared with current approaches.
|
Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
|
Mean Perceived Compatibility Score for the Selected Evidence-Informed Strategy
時間枠：Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
Perceived compatibility will be assessed using four adapted items from the Moore and Benbasat Perceived Characteristics of Innovating instrument.
Each item is scored from 1, extremely disagree, to 7, extremely agree.
Item scores will be averaged.
Scores range from 1 to 7. Higher scores indicate greater perceived compatibility with coalition needs, activities, and ways of working.
|
Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
|
Mean Perceived Ease-of-Use Score for the Selected Evidence-Informed Strategy
時間枠：Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
Perceived ease of use will be assessed using three adapted items from the Moore and Benbasat Perceived Characteristics of Innovating instrument.
Each item is scored from 1, extremely disagree, to 7, extremely agree.
Item scores will be averaged.
Scores range from 1 to 7. Higher scores indicate that the selected strategy is perceived as easier to understand and use.
|
Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
|
Mean Perceived Result-Demonstrability Score for the Selected Evidence-Informed Strategy
時間枠：Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
Perceived result demonstrability will be assessed using four adapted items from the Moore and Benbasat Perceived Characteristics of Innovating instrument.
Each item is scored from 1, extremely disagree, to 7, extremely agree.
One negatively worded item will be reverse-coded, and the four item scores will be averaged.
Scores range from 1 to 7. Higher scores indicate that the expected results of the selected strategy are perceived as more observable and easier to communicate.
|
Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
|
Mean Perceived Trialability Score for the Selected Evidence-Informed Strategy
時間枠：Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
Perceived trialability will be assessed using two adapted items from the Moore and Benbasat Perceived Characteristics of Innovating instrument.
Each item is scored from 1, extremely disagree, to 7, extremely agree.
Item scores will be averaged.
Scores range from 1 to 7. Higher scores indicate greater perceived ability to test the selected strategy before full implementation.
|
Intervention months 6, 9, and 12, after a candidate or selected strategy has been identified
|
|
Mean Evidence-Input Domain Score on the Structured Interview for Evidence Use
時間枠：Intervention months 6, 9, and 12
|
Evidence acquisition will be assessed using the six-item Input domain of the Structured Interview for Evidence Use brief form.
Items assess how often participants obtain evidence from professional networks, experts, academic journals, and training materials.
Each item is scored from 1, not at all, to 5, all the time.
Item scores will be averaged to produce a score ranging from 1 to 5. Higher scores indicate more frequent acquisition of evidence.
Mean scores will be reported separately for each assessment time point.
|
Intervention months 6, 9, and 12
|
|
Mean Evidence-Appraisal Process Domain Score on the Structured Interview for Evidence Use
時間枠：Intervention months 6, 9, and 12
|
Evidence appraisal will be assessed using the seven-item Process domain of the Structured Interview for Evidence Use brief form.
Items assess the importance participants place on factors such as study methods, use of multiple sources, strengths and limitations of the evidence, source trustworthiness, relevance, and cost.
Each item is scored from 1, not important, to 5, very important.
Item scores will be averaged to produce a score ranging from 1 to 5. Higher scores indicate greater importance placed on systematically evaluating evidence.
Mean scores will be reported separately for each assessment time point.
|
Intervention months 6, 9, and 12
|
|
Mean Evidence-Application Output Domain Score on the Structured Interview for Evidence Use
時間枠：Intervention months 6, 9, and 12
|
Evidence application will be assessed using four Output-domain items from the Structured Interview for Evidence Use brief form.
Items assess the importance of using evidence to support adoption decisions, determine fit with community needs, assess potential harms, and compare available strategies.
Each item is scored from 1, not important, to 5, very important.
Item scores will be averaged to produce a score ranging from 1 to 5. Higher scores indicate greater importance placed on applying evidence in coalition decisions.
Mean scores will be reported separately for each assessment time point.
|
Intervention months 6, 9, and 12
|
|
Percentage of Structured Evidence-Review Milestones Completed
時間枠：Intervention months 6 and 12
|
Coalition progress will be assessed using four prespecified milestones: evidence was reviewed, candidate strategies were compared, a selection decision was made, and the selected evidence-informed strategy was documented.
Each completed milestone receives one point.
The number of completed milestones will be divided by four and multiplied by 100.
Scores range from 0% to 100%.
Higher percentages indicate greater progress through the structured evidence-review and selection process.
|
Intervention months 6 and 12
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
協力者
協力者
捜査官
捜査官
- 主任研究者：Travis R Moore, PhD、University of Pittsburgh
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Moore TR, Chusan YAC, Sanderson E, Calancie L, Hennessy E, Appel JM, Ulseth M, Economos CD. Community-led change: Progress toward policy, systems, and environmental impacts through the Catalyzing Communities initiative. PLoS One. 2025 Nov 10;20(11):e0336482. doi: 10.1371/journal.pone.0336482. eCollection 2025.
- Moore TR, Calancie L, Hennessy E, Appel J, Economos CD. Changes in systems thinking and health equity considerations across four communities participating in Catalyzing Communities. PLoS One. 2024 Oct 23;19(10):e0309826. doi: 10.1371/journal.pone.0309826. eCollection 2024.
- Moore TR, Hennessy E, Chusan YC, Ashcraft LE, Economos CD. Considerations for using participatory systems modeling as a tool for implementation mapping in chronic disease prevention. Ann Epidemiol. 2025 Jan;101:42-51. doi: 10.1016/j.annepidem.2024.12.002. Epub 2024 Dec 15.
- Moore TR, Chusan YAC, Pachucki M, Kim B. A participatory systems approach for visualizing and testing implementation strategies and mechanisms: evidence adoption in community coalitions. Implement Sci Commun. 2025 Oct 1;6(1):96. doi: 10.1186/s43058-025-00788-9.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
研究開始
2027年1月1日
一次修了 (推定)
一次修了
2028年6月1日
研究の完了 (推定)
研究の完了
2029年6月1日
試験登録日
最初に提出
最初に提出
2026年8月27日
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
2026年8月31日
最初の投稿 (実際)
最初の投稿
2026年9月4日
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
2026年9月4日
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
2026年8月31日
最終確認日
最終確認日
2026年8月1日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- STUDY26070049
- 4R00HD109456-03 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
はい
IPD プランの説明
De-identified individual participant data included in the final analytic datasets underlying reported results will be shared.
These data may include cleaned participant-level survey responses, outcome scores, and derived participant-level variables.
Associated data dictionaries, codebooks, variable-derivation documentation, and analytic code will also be provided.
Direct identifiers, contact and linkage files, recordings, transcripts that cannot be safely de-identified, raw network-nomination files, and data presenting an unacceptable risk of deductive disclosure will not be shared.
Detailed network data may be masked, aggregated, or made available through controlled access following disclosure-risk review.
IPD 共有時間枠
Data and supporting information will become available no later than the date of the first associated publication or the end of the award period, whichever occurs first.
Materials will remain available for at least 10 years, subject to repository policies.
IPD 共有アクセス基準
Data will be deposited in ICPSR or another appropriate NIH-compliant repository.
Qualified researchers may request access by submitting a research proposal describing the scientific purpose, requested data, analysis plan, data-security procedures, and plans for dissemination.
Requests will be reviewed for scientific appropriateness, privacy and deductive-disclosure risk, consistency with participant consent, and compliance with applicable IRB and institutional requirements.
Access may require a data use agreement, appropriate ethics approval, secure data storage, and agreement not to re-identify or contact participants, redistribute the data, or use the data beyond the approved purpose.
Detailed network data may be restricted, masked, or aggregated when necessary to protect participants and participating coalitions.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。